Complete report $6,100. nbsp;DataPack test volumes, sales forecasts, supplier shares $3,950.
This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Spanish molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.
The report explores future marketing and technological trends in Spain; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semiautomated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.
Blood Group Genotyping
PCR, PCRRFLP, ASPCR or PCRSSP, Multiplex PCR,
Real Time PCR, Sanger DNA Sequencing, Pyrosequencing
Microarrays
BeadChip Array, BloodChip, Genome Lab SNP Stream,
Fluidic Microarray Systems, TaqMan OpenArray, MALDITOFMS,
MiniSequencing
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin,
Antigen Typing C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s,
Antiglobulin Direct, C3 + IgG, IgG,nbsp; C3,
Crossmatching Immediate Spin, Full Crossmatch,
Rh D, Du.
Infectious Disease Screening Tests
AIDS HIV NAT, HIV1/2, Cytomegalovirus,
Hepatitis HAV NAT, HBV NAT, HBs Ag,nbsp;nbsp;
AntiHBc, HCV NAT, HCV, ALT/SGPT, HTLVI/II, Parvovirus B19 NAT,
Syphilis, West Nile Virus NAT
Sales and Market Share Analysis
Sales and market share estimates for leading
suppliers of blood banking products by individual product.
Competitive Assessments
Strategic assessments of major suppliers and
emerging market entrants, including their sales,
product portfolios, marketing tactics, and new products in Ramp;D.
Market Segmentation Analysis
Comprehensive market segmentation
nbsp; analysis, including review of the market
nbsp; dynamics, trends, structure, size, growth,
nbsp;nbsp;and key suppliers.
Test volume and sales forecasts for over 40 blood typing,
nbsp; grouping and infectious disease screening tests,
nbsp; including NAT, by market segment:
nbsp;nbsp;nbsp;nbsp;nbsp; Blood Centers
nbsp;nbsp;nbsp;nbsp; Hospitals
nbsp;nbsp;nbsp;nbsp; Commercial/Private Laboratories
Current and Emerging Products
Analysis of current and emerging blood typing,
nbsp; grouping and infectious disease screening tests.
Review of automated and semiautomated
nbsp; analyzers.
Technology Review
Assessment of current and emerging
nbsp; technologies, and their potential applications
nbsp; for the blood banking market.
Comprehensive lists of companies developing
nbsp; or marketing new technologies and products, by test.
Strategic Recommendations
New product development
nbsp; opportunities with significant market appeal.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Contains 425 pages and 37 tables
NEXT ARTICLE